Science Talk

August 3, 2009 — Seven out of ten U.S. children have low levels of vitamin D, raising their risk of bone and heart disease, according to a study of over 6,000 children by researchers at Albert Einstein College of Medicine of Yeshiva University. The striking findings suggest that vitamin D deficiency could place millions of children at risk for high blood pressure and other risk factors for heart disease.

July 28, 2009 — For those with diabetes, even a small foot wound can heal poorly, leading in some cases to amputation of toes, feet or legs. Now, researchers at Albert Einstein College of Medicine of Yeshiva University and Stanford University have shown that a drug used to remove excess iron from the body reduces by nearly half the time it takes diabetic wounds to heal in mice.

July 22, 2009 — A cellular protein that may prevent nerve cells from dying also helps to improve insulin action and lower blood glucose levels, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University in collaboration with scientists at University of California, Los Angeles (UCLA).

July 9, 2009 — Scientists at Albert Einstein College of Medicine of Yeshiva University have devised a laboratory test for predicting whether microbicides against HIV are safe for human use. The researchers have also discovered why several supposedly "safe" microbicides made women more susceptible to HIV infection. The study appears today in the online version of the Journal of Infectious Diseases.

http://www.einstein.yu.edu - Former Army specialist Dan Hof, a veteran of the conflict in Iraq, sustained a concussion in 2005 while deployed and has been struggling with troubling symptoms of his injury ever since. Dan is one of the 20 participants in a study of mild traumatic brain injury in veterans led by Michael Lipton, M.D., Ph.D., at Albert Einstein College of Medicine. In cooperation with the Resurrecting Lives Foundation, Dr. Lipton is using advanced MRI techniques and cognitive tests to investigate the effect of repeated combat-related blast exposures on the brains of veterans with the goal of improving diagnostics and treatment.